Stay updated on Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Sign up to get notified when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.

Latest updates to the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check51 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the detailed description of a clinical study for lirentelimab (AK002) and its inclusion and exclusion criteria for participants. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference29%
- Check59 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Lirentelimab in Eosinophilic Esophagitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lirentelimab in Eosinophilic Esophagitis Clinical Trial page.